Francoise Debrus - Alterola Biotech Insider

ALTA -- USA Stock  

USD 1.25  0.00  0.00%

Ms. Francoise Debrus is an Independent Member of the Supervisory Board of Altarea SCA as well as Chairman of the Company Audit Committee. She is a graduate of the Ecole nationale du genie rural des eaux et des forets and of the Institut national agronomique ParisGrignon. Between 1984 and 1987, she was head of the economic and agricultural production department of the Ministry of Agriculture and Forestry. From 1987 she was an auditor and then audit team manager of the Internal Audit Department of Caisse Nationale de Credit Agricole, before becoming head of management control and then of financial management at Unicredit. In 1997, she was appointed head of the debt collectionlending department of the Finance Division of Credit Agricole SA. In 2001, she became head of finance and tax at the Federation Nationale du Credit Agricole . In 2005, she was appointed Chief Financial Officer of the Caisse Regionale dIledeFrance, and since March 2, 2009, she was with Credit Agricole Assurances as Head of Investments. She also holds other mandates, including Member of the Supervisory Board of Fonciere Developpement Logement and Fonciere des Murs, Permanent representative of Predica as member of the Supervisory Board of Fonciere Paris France SA and Director of Eurosic and Medica.
Age: 57  Executive Since 2009      

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Found 11 records


Joseph LacsonMetro Pacific Investments Corpo
Johann QuiazonMegaworld Corporation
Cheryll SerenoMegaworld Corporation
Anna LlovidoMegaworld Corporation
Cristina GilFernandezMetro Pacific Investments Corpo
Rolando SiatelaMegaworld Corporation

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. As of March 26, 2018, Alterola Biotech, Inc. operates as a subsidiary of London Pharma Holdings Limited. Alterola Biotech operates under Conglomerates classification in USA and traded on OTC Market. It employs 1 people.Alterola Biotech (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Alterola Biotech Leadership Team

Patrick Mazieres, Finance Director of Cogedim
Michael Freitag, President CEO, Treasurer, Secretary, Director
Christian Gournay, Deputy CEO in charge of Residential Property, Regions and Institutional Relations, Member of the Executive Committee
CharveriatLouis Blandine, Director of Marketing
Gilles Boissonnet, Deputy CEO in charge of retail property, Chairman of the Management Board of Altarea France, Member of the Executive Committee
Kyler Hardy, Chairman of the Board
Olivier Dubreuil, Permanent Representative of JN Holding on the Supervisory Board
Alain Dassas, Independent Member of the Supervisory Board Representing APG (ABP Fund)
Gautier Taravella, Member of the Supervisory Board
Frederic Laloum, Deputy CEO in charge of marketing and Member of the Management Board of Altarea France
Philippe Albert, Deputy CEO of Altarea France
Gilbert Plummerel, Cogedim Market Director
Jocelyn Verdelon, Commercial Property Investment Director at Cogedim
Francoise Debrus, Independent Member of the Supervisory Board
Philippe Ulivieri, Regional Property CEO at Cogedim
Rene Lauritsen, President CEO, Principal Executive Officer, CFO, Principal Financial Officer, Principal Accounting Officer, Director
Olivier Esteve, Permanent Representative of Fonciere des Regions as an Independent Member of the Supervisory Board
Ian Talbot, Director
Christian Musset, Chairman of Cogedim Vente
Laurian Douin, Director of Investment Operations of Altarea Cogedim Entreprise
Michael Bennett, Director
Ludovic Castillo, Managing Director of Altarea Italia, Member of the Executive Committee
Dominique Rongier, Independent Member of the Supervisory Board
Laurent Campredon, Legal Property Director of Altarea France
Michael OBrien, CFO
JeanFrederic Heinry, CEO of Altarea Cogedim Entreprise ? Promotion
Philippe Mauro, Group General Secretary
Nathalie Bardin, Group Communications Director
Ioannis Tsitos, Director
Peter Maddocks, CEO, Director
Philippe Bouvier, Cogedim Investment Director
Christopher Harris, Director
Alain Taravella, President Co-Manager, Member of the Executive Committee
Eric Dumas, Finance Director, Member of the Executive Committee
Alain Jodar, Deputy CEO in charge of portfolio and Member of the Management Board of Altarea France
Alan Carter, Interim President CEO
Manuel Colleaux, Deputy Regional CEO of Cogedim
Stephane Theuriau, Deputy CEO in charge of Office Property and Private Equity, Chairman of Cogedim Entreprise, Member of the Executive Committee
Christophe Bacque, Chairman of COGEDIM Residence
Jacques Nicolet, Chairman of the Supervisory Board, Member of the Executive Committee
Emeric Servin, Permanent Representative of Predica - Credit Agricole Assurances on the Supervisory Board
Fabrice Allouche, CEO of Cogedim Entreprise
Matthieu Taravella, Member of the Supervisory Board
Bruno Poulain, Director for Sustainable Development, Communications and Human Resources

Stock Performance Indicators

Current Sentiment - ALTA

Alterola Biotech Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in Alterola Biotech. What is your sentiment towards investing in Alterola Biotech? Are you bullish or bearish?
50% Bullish
50% Bearish

Alterola Biotech Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Alterola Biotech and Amazon. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.